TruAlt Bioenergy Files for IPO with Rs 750 Crore Fresh Issue

TruAlt Bioenergy Ltd., a Bengaluru-based ethanol production company, has initiated the process of raising funds through an initial public offering (IPO). The company has submitted its preliminary documents to the Securities and Exchange Board of India (SEBI) as it prepares to enter the public market. The proposed IPO will include a combination of fresh equity issuance and an offer-for-sale (OFS) by the company’s promoters.
Structure of the IPO and Fund Allocation
TruAlt Bioenergy’s IPO is structured to raise a significant amount of capital through a mix of new equity shares and an offer-for-sale. The fresh issuance of equity shares is expected to raise Rs 750 crore, while the OFS will consist of up to 36 lakh equity shares owned by the company’s promoters. The face value of each share is set at Rs 10.
The company has earmarked the proceeds from the IPO for various strategic purposes. A substantial portion, Rs 425 crore, will be allocated to fund working capital requirements, which are crucial for the company’s day-to-day operations and growth. Additionally, Rs 172.68 crore will be utilized for setting up multi-feed stock operations, a key component of TruAlt Bioenergy’s expansion strategy. The remaining funds will be directed towards general corporate purposes, providing the company with the financial flexibility needed to execute its business plans.
Promoter’s Offer-for-Sale and Potential Pre-IPO Placement
The offer-for-sale component of the IPO includes up to 18 lakh equity shares each owned by Dhraksayani Sangamesh Nirani and Sangamesh Rudrappa Nirani, both key promoters of the company. This move allows the promoters to partially exit their investment while raising capital for the company’s future growth.
Moreover, TruAlt Bioenergy may consider raising Rs 150 crore through a pre-IPO placement round. If this placement is successfully completed, the size of the fresh equity issue will be reduced accordingly, making the IPO more flexible and potentially increasing investor confidence.
Conclusion: TruAlt Bioenergy Ltd.’s decision to go public marks a significant milestone in the company’s growth trajectory. The funds raised through the IPO will be instrumental in supporting its operational and expansion plans, particularly in enhancing its production capabilities and meeting working capital needs. As the company moves closer to its public debut, the success of this IPO will be closely watched by investors and industry observers alike.
Your path to financial growth starts with smart investing. Discover the Upcoming IPO and leap toward new and exciting investing opportunities. Invest today!
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Aug 20, 2024, 1:37 PM IST
- Symbiotec Pharmalab Share Price: Stock Lists at Flat on NSE
- Hy-Tech Engineers Share Price: Stock Lists at 41.51% Premium on NSE
- Skyways Air Services Share Price: Stock Lists at 10.14% Discount on NSE
- Augmont Enterprises Share Price: Stock Lists at 21.95% Premium on NSE
- Upcoming IPOs This Week (August 31–September 4, 2026): Purple Style Labs, Deepa Jewellers and Others


